GlassScriptPhysician profile
Blaise C Woeste
NPI 1245247857
$1,650.73
in general payments reported to CMS, 2019-2025
18 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $78.03 · 2021: $49.44 · 2022: $574 · 2023: $83.11 · 2024: $265 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $364.48 | 2022-2025 | Mini Maxlock Extreme, Asnis, Actishield |
| Treace Medical Concepts, INC. | $339.63 | 2022-2025 | |
| Convatec INC. | $203.62 | 2024 | |
| Horizon Therapeutics Plc | $124.25 | 2019 | |
| Grt US Holding, INC. | $102.07 | 2020-2022 | |
| Amniox Medical, INC. | $93.75 | 2019 | |
| Depuy Synthes Sales INC. | $87.18 | 2025 | Motoband |
| Smith+Nephew, INC. | $65.42 | 2019-2024 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $50.00 | 2023 | Nuzyra |
| Melinta Therapeutics, LLC | $47.02 | 2021-2022 | |
| Kerecis Limited | $40.28 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Djo, LLC | $36.45 | 2021-2023 | Cmf |
| Arthrosurface Incorporated | $19.21 | 2020 | |
| Orthofix Medical, INC. | $18.22 | 2024 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.25 | 2025 | Jublia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.58 | 2021 | |
| Triad Life Sciences INC. | $14.03 | 2022 | |
| Integra Lifesciences Corporation | $13.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaise Woeste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.